Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent.

Dunkley, S M; Mackie, F

Dunkley, S M; Mackie, F.

Affiliation

Dunkley SM; Department of Haematology, Prince of Wales Hospital, Randwick 2031, Sydney, Australia. dunkley@sesahs.nsw.gov.au

Hematology ; 8(4): 263-4, 2003 Aug.

Article in En | MEDLINE | ID: mdl-12911945

Subject(s)

Factor VII/therapeutic use; Hemorrhage/drug therapy; Kidney Transplantation/adverse effects; Recombinant Proteins/therapeutic use; Adolescent; Catheterization/adverse effects; Factor VIIa; Female; Glomerulosclerosis, Focal Segmental/complications; Glomerulosclerosis, Focal Segmental/therapy; Hemorrhage/etiology; Humans; Kidney Transplantation/methods; Vascular Patency; Venous Thrombosis/etiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Factor VII / Kidney Transplantation / Hemorrhage Type of study: Etiology_studies Limits: Adolescent / Female / Humans Language: En Journal: Hematology Journal subject: HEMATOLOGIA Year: 2003 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links